Skip to main content

Closed

DXCM: DexCom, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+11.3% / yr

Operating margin22.9%

ROIC21.6%

Financially safe

Strong

Debt / equity0.51×

Interest coverage128.0×

Current ratio1.73×

Valuation

Unrated

P/E ratio32.2×

DexCom, Inc.

DXCMNASDAQ Global Select·USD·Closed

DexCom, Inc.

DXCMNASDAQ·USD·Closed

$83.45

+11.95%

$83.45

+$8.91 (11.95%)

52W Range

96thpctl

Volume

2.03×avg

Mkt Cap

32.20BUSD

P/E

32.2TTM

Div Yield

–ann

52W Range

96thpctl

Volume

2.03×avg

Market Cap

32.20BUSD

P/E Ratio

32.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings